Jushi Holdings (JUSHF) Depreciation & Amortization (CF) (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Depreciation & Amortization (CF) came in at $7.9 million in Q1 2026, down 1.11% year-on-year from $8.0 million in Q1 2025, and up 10.51% on a QoQ basis from $7.2 million in Q4 2025.
Jushi Holdings (JUSHF) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $7.9 million in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 1.11% year-over-year to $7.9 million in Q1 2026; TTM through Mar 2026 was $30.9 million, a 0.61% decrease from a year earlier, with the FY2025 full-year figure at $31.0 million, up 3.68% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $7.9 million, up from $7.2 million in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for JUSHF reached as high as $10.8 million in Q4 2022 and fell as low as $3.2 million in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $7.2 million across 5 years, with a median of $7.4 million in 2024.
- Across the five-year window, Depreciation & Amortization (CF) jumped 261.76% in 2022 and tumbled 37.13% in 2023, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $10.8 million in 2022, then sank by 37.13% to $6.8 million in 2023, then gained by 16.16% to $7.9 million in 2024, then slipped by 9.08% to $7.2 million in 2025, then increased by 10.51% to $7.9 million in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $7.9 million in Q1 2026, $7.2 million in Q4 2025, and $7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 7.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.95 Mn |
| Mar 31, 2026 | 7.95 Mn |
| Dec 31, 2025 | 7.19 Mn |
| Dec 31, 2025 | 7.19 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 7.97 Mn |
| Jun 30, 2025 | 7.97 Mn |
| Mar 31, 2025 | 8.04 Mn |
| Mar 31, 2025 | 8.04 Mn |
| Dec 31, 2024 | 7.91 Mn |
| Dec 31, 2024 | 7.91 Mn |
| Sep 30, 2024 | 7.77 Mn |
| Sep 30, 2024 | 7.77 Mn |
| Jun 30, 2024 | 7.38 Mn |
| Jun 30, 2024 | 7.38 Mn |
| Mar 31, 2024 | 6.84 Mn |
| Mar 31, 2024 | 6.84 Mn |
| Dec 31, 2023 | 6.81 Mn |
| Dec 31, 2023 | 6.81 Mn |